Pregnancy is associated with decreased cardiac proteasome activity and oxidative stress in mice. by Iorga, Andrea et al.
UC Davis
UC Davis Previously Published Works
Title
Pregnancy is associated with decreased cardiac proteasome activity and oxidative stress in 
mice.
Permalink
https://escholarship.org/uc/item/9z79h5n8
Journal
PLoS One, 7(11)
Authors
Iorga, Andrea
Dewey, Shannamar
Partow-Navid, Rod
et al.
Publication Date
2012
DOI
10.1371/journal.pone.0048601
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Pregnancy Is Associated with Decreased Cardiac
Proteasome Activity and Oxidative Stress in Mice
Andrea Iorga1, Shannamar Dewey2, Rod Partow-Navid1, Aldrin V. Gomes2, Mansoureh Eghbali1*
1Department of Anesthesiology, Division of Molecular Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United
States of America, 2Department of Neurobiology, Physiology and Behavior, University of California Davis, Davis, California, United States of America
Abstract
During pregnancy, the heart develops physiological hypertrophy. Proteasomal degradation has been shown to be altered in
various models of pathological cardiac hypertrophy. Since the molecular signature of pregnancy-induced heart hypertrophy
differs significantly from that of pathological heart hypertrophy, we investigated whether the cardiac proteasomal
proteolytic pathway is affected by pregnancy in mice. We measured the proteasome activity, expression of proteasome
subunits, ubiquitination levels and reactive oxygen production in the hearts of four groups of female mice: i) non pregnant
(NP) at diestrus stage, ii) late pregnant (LP), iii) one day post-partum (PP1) and iv) 7 days post-partum (PP7). The activities of
the 26 S proteasome subunits b1 (caspase-like), and b2 (trypsin-like) were significantly decreased in LP (b1:83.2661.96%;
b2:74.7461.7%, normalized to NP) whereas b5 (chymotrypsin-like) activity was not altered by pregnancy but significantly
decreased 1 day post-partum. Interestingly, all three proteolytic activities of the proteasome were restored to normal levels
7 days post-partum. The decrease in proteasome activity in LP was not due to the surge of estrogen as estrogen treatment
of ovariectomized mice did not alter the 26 S proteasome activity. The transcript and protein levels of RPN2 and RPT4
(subunits of 19 S), b2 and a7 (subunits of 20 S) as well as PA28a and b5i (protein only) were not significantly different
among the four groups. High resolution confocal microscopy revealed that nuclear localization of both core (20S) and RPT4
in LP is increased ,2-fold and is fully reversed in PP7. Pregnancy was also associated with decreased production of reactive
oxygen species and ubiquitinated protein levels, while the de-ubiquitination activity was not altered by pregnancy or
parturition. These results indicate that late pregnancy is associated with decreased ubiquitin-proteasome proteolytic activity
and oxidative stress.
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Introduction
Cardiac hypertrophy, defined as an enlargement of the
ventricles and cardiomyocytes, can be adaptive or maladaptive,
and usually occurs in response to hemodynamic stress from
volume or pressure overload. Sustained pressure overload leads to
concentric hypertrophy, which is characterized by increased wall
thickness without a concomitant chamber enlargement. However,
in response to normal exercise or pregnancy, physiological or
eccentric hypertrophy develops [1], which is characterized by an
increase in cardiac pumping ability and muscle mass. Volume
overload-induced hypertrophy is characterized by a proportional
enlargement of the chamber size and the wall thickness [2] and is
reversible without aberrant effects on cardiac function [3], [4], [5].
In these aspects, pregnancy- and exercise-induced hypertrophies
are similar. However, pregnancy is also accompanied by acute
changes in the mother’s hormonal environment, and unlike
exercise, the force demand placed on the heart is continuous as
opposed to sporadic.
The ubiquitin-proteasome system (UPS) is the major pathway
for protein degradation in the heart to remove damaged and
misfolded proteins [6]. Regulation of proteasome function can
occur through the association of the core 20 S proteasomal
complex with different regulatory complexes such as 19 S or 11 S
that affect proteasomal assembly and activity [6], [7], [8]. In
general, the covalent binding of multiple ubiquitin molecules to
the target protein dictates its degradation by the 26 S proteasome
[9]. Following attachment of ubiquitin molecules to a target
protein, the 19 S regulatory subunits recognize the polyubiquitin
tags and transfer the protein substrate to the inner pore of the 20 S
catalytic core where the polypeptide is degraded [10]. Proteasome
dysfunction in the heart leads to accumulation of abnormal,
damaged and misfolded proteins [11].
Altered ubiquitin-proteasome system regulation has been
reported in different types of cardiac hypertrophy and myopathy
[6], [12]. However, the precise role of the UPS in physiological
heart hypertrophy during pregnancy is not yet known. To
investigate the role of the UPS in the murine heart during
pregnancy, we measured proteasome activity, proteasome subunit
expression and subcellular distribution, ubiquitination and de-
ubiquitination levels, as well as reactive oxygen production in four
groups of female mouse hearts: i) non pregnant (NP) at diestrus
stage, ii) late pregnant (LP), iii) one day post-partum (PP1) and iv) 7
days post-partum (PP7). We found that pregnancy is associated
with decreased proteasome activity, protein ubiquitination, and
oxidative stress.
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Experimental Procedures
Animals and Treatment
Young adult female (3–4 months) mice (C57BL/6) in non
pregnant (NP, at diestrus stage), late pregnant (LP, day 20 of
pregnancy), 1 day post-partum (PP1), 7 days post-partum (PP7) as
well as ovarictomized (OVX) mice were used. OVX mice were
treated with a single subcutaneous 10-day continuous release 17b-
estradiol (E2) pellet (0.012 mg/pellet, Innovative Research of
America, Sarasota, FL), or placebo pellets (containing 5 com-
pounds: cholesterol, lactose, cellulose, phosphates and cerates) as
vehicle for E2. This study was carried out in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol received approval from the Division of Laboratory
Animal Medicine at the University of California, Los Angeles
(Protocol Number: 2003-111-13).
Real Time PCR
Total RNA was isolated from hearts using Trizol (Invitrogen)
and reverse transcribed with gene specific primers using the
Omniscript RT kit (Qiagen). Controls were: (1) the reaction
without reverse transcriptase and (2) H2O instead of cDNA. The
primer sequences used were as follows: RPN2 sense 59-CAG CTC
TCA TCA TGA TCC AAC AG-39 and anti-sense 59-ACA GGT
AGG AGT ATA AGC CAA TG-39, RPT4 sense 59-TGA TCA
TGG CTA CAA ACA GAC CA-39 and anti-sense 59- CTC AGG
TCT GCT CCA TTA AAG C -39, b2 sense 59- AGC CAA GAA
GCT AGT GAG TGA G-39and anti-sense 59- TAT CCA ACC
ACC CAC AGC ACC -39, a7 sense 59-AAA CAT CGA ACT
TGC CGT CAT GA-39 and anti-sense 59-GGC CCA CAG CAC
CGA GGC T-39, and PA28a sense 59-GGC CAC ACT GAG
GGT CCA TC-39 and anti-sense 59-ACA CAG GTC TTC ACG
GAA CAC A-39. GAPDH transcript levels were used as an
internal control.
Western Blot
Whole heart cell lysates were prepared by homogenizing the
hearts in: 50 mM Tris (pH 7.5), 1 mM EDTA, 5 mM MgCl2,
150 mM NaCl, 1 mM DTT supplemented with Phosphatase and
Protease Inhibitor cocktails (Roche). The samples were then
centrifuged at 12,000 g for 10 min and the supernatants were
collected. The protein concentrations were measured and 100 mg
of protein was treated with SDS/DTT loading buffer prior to gel
electrophoresis. The blots were probed with anti-RPN2, -RPT4 -
a7, PA28a and –b5i (Enzo Life Sciences, 1:500) and with anti-
mono- and polyubiquitinated conjugates (Enzo Life Sciences,
clone FK2, 1:1000). Quantification of protein levels was achieved
using the Metamorph software for protein levels of the proteasome
subunits. For the quantification of ubiquitinated protein levels,
100 mg of protein was subjected to standard Western Blotting
procedure and immunolabeled with anti-mono- and polyubiqui-
tinated antibodies. The fluorescence intensity of the entire lane
was assessed in each group using ImageJ software and average
fluorescence intensities were normalized to NP levels.
Isolation of Cardiomyocytes
The hearts were quickly removed and perfused through the
aorta with the following solutions: (i) Ca2+-free Tyrode solution
containing (in mM): 130 NaCl, 5.4 KCl, 1 MgCl2, 0.33 NaH2PO4,
10 HEPES, 5.5 glucose (pH adjusted to 7.35–7.37 with NaOH) for
5 minutes, (ii) Ca2+-free Tyrode solution containing 160.4 U/ml
Collagenase Type II (Worthington) and 0.45 U/ml Protease Type
XIV (Sigma) for ,15 min; and (iii) Krebs solution containing (in
mM): 100 K-glutamate, 10 K-aspartate, 25 KCl, 10 KH2PO4, 2
MgSO4, 20 taurine, 5 creatine base, 0.5 EGTA, 5 HEPES, 20
glucose (pH adjusted to 7.2 with KOH) for 5 minutes. The
solutions were oxygenated with 5% CO2 and 95% O2 prior to use
and were maintained at 3761uC.
Immunocytochemistry and Imaging
Freshly isolated cardiomyocytes were fixed in cold acetone for
10 min at 220uC. The isolated cells were incubated with 10%
normal goat serum (NGS) to block the background and were then
stained with anti-core and anti-RPT4 (Enzo Life Sciences, 1:200)
primary antibodies in 1% NGS and 0.2% Triton X-100 in PBS at
4uC overnight. Cells were incubated with Alexa 488 goat anti-
rabbit or Alexa 568 goat anti-mouse secondary antibodies. Images
were acquired at 0.0575 nm per pixel with a confocal microscope
(Olympus Fluoview). For dihydroethidium (DHE, Invitrogen)
staining, whole hearts were excised, washed thoroughly with ice-
cold PBS and frozen in O.C.T. compound. Fresh 6 mm sections
were cut with a cryostat then incubated with 10 mM DHE in
Krebs-HEPES buffer (containing in mM: 99 NaCl, 4.69 KCl, 25
NaHCO3, 1.03 KH2PO4, 5.6 D-Glucose, 20 Na-HEPES, 2.5
CaCl2 and 1.2 MgSO4) for 1 hr and 15 min in the dark at room
temperature. The sections were then washed 3 times for 1.5 hrs in
the dark with Krebs-HEPES buffer, mounted with Prolong
Antifade Reagent (Invitrogen) and visualized with a confocal
microscope (Olympus Fluoview).
Proteasome Activity Assay
Heart cell lysates were prepared by homogenizing the hearts in:
50 mM Tris, 1 mM EDTA, 5 mM MgCl2, 150 mM NaCl, 1 mM
DTT, pH 7.5. The samples were then centrifuged at 12,000 g for
10 min and the supernatants were collected. Proteasome activity
of heart homogenates (20 mg/sample) was measured with fluores-
cent substrates of Z-LLE-AMC (b1), Boc-LSTR-AMC (b2) and
Suc-LLVY-AMC (b5) as previously described [13], [14]. The
proteasome activity was measured in the presence and absence of
proteasome inhibitors (40 mM Z-Pro-Nle-Asp-CHO for b1,
40 mM epoxomicin for b2, and 20 mM epoxomicin for b5). Assays
were carried out in a total volume of 100 ml. The ATP-dependent
26 S proteasome activities were measured in the presence of
50 mM Tris, 1 mM EDTA, 150 mM NaCl, 10 mM MgCl2,
0.1 mM ATP, pH 7.5. The ATP-independent 20 S proteolytic
activity for b5 was carried out in 25 mM HEPES (pH 7.5),
0.5 mM EDTA, and 0.03% SDS. The buffer composition was
25 mM HEPES (pH 7.5), 0.5 mM EDTA, 0.05% Nonidet P-40,
and 0.001% SDS for b1 and b5 20S activity measurements. These
buffers used for 20 S proteasome activity were previously found to
be optimal for proteasome activity in lysates from mouse heart
tissue [13], [14]. Each assay was conducted in the absence and
presence of a specific proteasome inhibitor ((40 mM Z-Pro-Nle-
Asp-H for b1, 60 mM epoxomicin for b2 and 20 mM epoxomicin
for b5) to determine proteasome-specific activity. Released AMC
was measured using a Fluoroskan Ascent fluorometer (Thermo
Electron) at an excitation wavelength of 390 nm and an emission
wavelength of 460 nm.
De-ubiquitination Assay
De-ubiquitination activity was determined using 5 mg of protein
in 50 mM Tris, 150 mM NaCl, 1 mM EDTA, 5 mM MgCl2,
2 mM DTT, pH 7.5. All assays were carried out in a final volume
of 100 ml. The reaction was initiated by adding 400nM ubiquitin-
AMC (Enzo Life Sciences). Each assay was conducted in the
absence and presence of a de-ubiquination inhibitor (10 mM N-
ethylmaleimide (NEM)) to determine de-ubiquitination-specific
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activity. Released AMC was measured using a Thermo Fluor-
oskan Ascent fluorometer (Thermo Electron) at an excitation
wavelength of 390 nm and an emission wavelength of 460 nm.
ELISA Assay
1mg of protein lysate was bound overnight at 4˚C on a 96 well-
ELISA plate, washed 4 times, and blocked with BSA. 100 ml of
FK1 (1:1000 dilution) detection antibody (which only recognizes
polyubiquitinated proteins and not monoubiquitinated or free
ubiquitin) was added for 1 h, washed, and an anti-mouse HRP-
conjugated secondary antibody was added for 1 hr. After washing
the secondary antibody, 100 ml of Sureblue tetramethylbenzidine
substrate (KPL Inc.) was added and incubated for 15 min. The
reaction was stopped using 1 M HCl and absorbance was
measured at 450 nm. Positive (pentaubiquitin chains, Enzo Life
Sciences) and negative controls (BSA) were used to validate the
assay.
Statistics
One-way ANOVA using SPSS SigmaStat 3.0 was used for
statistical analysis. P values,0.05 were considered significant.
Values are mean 6 SEM.
Results
Proteasome Activity of 26S is Decreased in LP
During pregnancy, the heart develops physiological hypertro-
phy as a result of the natural volume overload (Fig. 1). However,
the ratio of the heart weight to body weight decreases in LP due to
a significant increase in body weight at the end of pregnancy as we
reported previously [15]. Interestingly, the heart weight is reversed
partially one day post partum (PP1) and fully one week post
partum (PP7).
To examine whether the proteasome function is altered in the
heart in late pregnancy, we measured the proteasome activity of
total 26 S ATP-dependent as well as the 20 S ATP-independent
proteasome. Regarding 26 S, the relative caspase-like catalytic b1
subunit activity was decreased from 10066.82% in NP to
83.2661.96% in late pregnancy, and was restored fully even
one day post-partum (Fig. 2). The trypsin-like b2 subunit activity
was also decreased in late pregnancy from 100613.72% in NP to
74.7461.7% in LP, and was only fully restored in PP7
(111.5668.7%). Interestingly, the chymotrypsin-like b5 activity
of the proteasome was significantly decreased 1 day post-partum
(from 10064.7% in NP to 69.6264.5% in PP1). All three
proteolytic activities of the 26 S proteasome were fully restored to
normal levels 7 days after parturition (Fig. 2). Unlike 26 S, the
proteasome activity of all three subunits of 20 S was not altered in
LP (Fig. 2). However, the activity of b1 and b2 subunits was
significantly lower 7 days after parturition (from 100613.72% in
NP to 64.6963.89% in PP7 and from 100613.35% in NP to
55.4164.63% in PP7, respectively (Fig. 2).
Proteasome Activity is not Regulated by Estrogen
Therapy
The levels of estrogen increases steadily during pregnancy and
reach their maximum levels at the end of pregnancy. To elucidate
whether decreased proteasome activity at the end of pregnancy
was a result of the surge of estrogen, ovariectomized (OVX) mice
were treated with E2 or placebo using continuous release pellets
for 10 days. The 26 S ATP-dependent proteasome activity was not
affected by estrogen treatment, as the activities of the three
subunits were not significantly different between E2 and placebo
groups (Fig. 3). Therefore, the reduced proteasome activity in late
pregnancy could not be explained by the rise of estrogen levels at
the end of pregnancy.
The Transcript and Protein Levels of Proteasome
Subunits are not Modified by Pregnancy
To elucidate whether the observed decrease in the proteasome
proteolytic activity of 26 S in LP is due to decreased gene
expression, we have performed Real-Time qPCR to quantify the
transcript levels of the subunits of 19 S and 20 S. Because the 20 S
proteasome can also associate with an 11S regulator (PA28) that
can modulate proteolytic activity of the 26 S complex, we also
examined the transcript levels of the PA28a subunit of the 11S/
PA28 regulator. There were no significant differences in the
transcript levels of these subunits neither with pregnancy nor up to
one week after delivery (in PP1 and PP7, Fig. 4). Western Blot
analysis also revealed no significant differences in the expression
levels of RPN2 and RPT4 (subunits of 19 S, Fig. 5A–D), in a7 (a
subunit of 20S, Fig. 5E–F), in PA28a (Fig. 5G–H) nor in b5i
(Fig. 5I–J) with pregnancy or after partum in the four groups
mentioned above. For b5i, the two bands labeled with 26kDa and
Figure 1. The increased in heart weight of LP mice is reversed
post-partum. Heart weights (HW, A), body weights (BW, B) and HW/
BW (C) in non-pregnant (NP, black bars, n = 8), late pregnant (LP, white
bars, n = 11), one day post-partum (PP1, grey bars, n = 6) and seven days
post-partum (PP7, shaded bars, n = 5) mice. Values are mean 6 SEM,
*p,0.05 and **p,0.001 vs. NP, #p,0.05 and ##p,0.001 vs. LP,
‘p,0.05 and ‘‘p,0.001 vs. PP1.
doi:10.1371/journal.pone.0048601.g001
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30kDa, correspond to b5i and b5i containing its pro-peptide,
respectively (Fig. 5I). Both bands were taken into consideration in
the quantification of protein levels (Fig. 5J). Quantification of
either band independent of the other also showed no difference
between groups (data not shown).
Pregnancy is Associated with Increased Nuclear Labeling
of 20S core and 19S RPT4 in Cardiomyocytes
To examine whether there are any changes in the subcellular
distribution of proteasomal subunits in cardiomyocytes in LP, we
have performed high resolution confocal microscopy. Fig. 6A
shows typical examples of high resolution confocal images of
cardiomyocytes co-labeled with anti-core (an antibody which
recognizes six 20S subunits: a5/7, b1, b5, b5i, and b7) and anti-
RPT4 (a subunit of 19S) antibodies. In NP, the vast majority of the
stained proteins resided in the t-tubules and the nuclear labeling
was very weak (Fig. 6A). In late pregnancy however, there is
increased nuclear localization of both core and RPT4, which was
reversed one week after parturition. In fact, quantification of the
nuclear labeling revealed approximately a 2-fold upregulation of
nuclear labeling with pregnancy (from 160.04 to 1.9760.20 for
core and from 160.04 to 1.7360.16 for RPT4). The increased
nuclear labeling of both proteins was sustained one day post
partum (1.9560.17 for core and 1.7360.06 for RPT4) and was
only reversed back to NP levels seven days after delivery (to
0.8860.06 for core and 1.1560.07 for RPT4, Fig. 6B).
Figure 2. Proteasome activity of 26 S, but not 20 S is reduced in late pregnancy. Activity of different proteasomal beta subunits of the 26 S
(A) and 20 S (B) was measured after initiating the reaction with: Z-LLE-AMC (b1), Boc-LSTR-AMC (b2) and Suc-LLVY-AMC (b5) for non pregnant (NP,
black bars), late pregnant (LP, white bars), one day post-partum (PP1, grey bars) and seven days post-partum (PP7, shaded bars). The fluorescence
values in arbitrary units are represented as mean 6 SEM *p,0.05 vs. NP (n = 4 mice per group) and are normalized to NP levels. The raw proteasome
activity values for the NP group are as follows (in nmol/min/mg protein): for the 26 S ATP-dependent activities, b1 was 0.1160.01, b2 was 0.0460.01
and b5 was 0.1660.01, while for the 20 S activity, b1 was 0.2160.03, b2 was 0.1560.02 and b5 was 0.1260.01.
doi:10.1371/journal.pone.0048601.g002
Figure 3. Proteasome activity of the 26S is unaffected by estrogen treatment. Activity of the different proteasomal beta subunits of the
26 S were measured after initiating the reaction with: Z-LLE-AMC (b1), Boc-LSTR-AMC (b2) and Suc-LLVY-AMC (b5) in ovariectomized female mice
treated with placebo (Placebo, black bars) or with 17 b-estradiol for 10 days (E2, white bars). The fluorescence values in arbitrary units are normalized
to Placebo levels and represented as mean 6 SEM (n= 4 mice per group).
doi:10.1371/journal.pone.0048601.g003
Pregnancy and Cardiac Proteasome
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Pregnancy is Associated with Decreased Production of
Reactive Oxygen Species
Since the nuclear proteasome selectively degrades oxidatively-
damaged histones in the nuclei of mammalian cells [16], we
performed a qualitative dihydroethidium (DHE) staining of
cardiac cross-sections to assess the levels of reactive oxygen species
production. We have found that late pregnancy is associated with
decreased levels of reactive oxygen species compared to NP, and
these levels remain low up to one week after parturition (Fig. 7), as
the average intensity of DHE staining normalized to NP levels is
reduced about 5-fold and partially recovers only seven days post-
partum (0.19860.010 in LP, 0.21360004 in PP1, and
0.40560.030 in PP7, normalized to NP).
Pregnancy is Associated with Decreased Levels of
Ubiquitinated Proteins
To further elucidate the underlying mechanism for the observed
decrease of 26S proteasome activity in late pregnancy, we
quantified polyubiquitinated proteins in the heart using two
different methods. Western Blot analysis against mono- and
polyubiquitinated proteins revealed that ubiquitinated protein
levels are significantly decreased in late pregnancy from 160.05 in
NP to 0.6060.06 in LP, and they remain low 7 days post-partum
(0.6560.04, in arbitrary units normalized to NP, Fig. 8A–C).
Reduced polyubiquitinated protein levels in LP were also
confirmed by ELISA: the relative amount was significantly
downregulated from 100610.41% in NP to 66.6863.69% in LP
(Fig. 8D). In order to examine whether the observed decrease in
the levels of ubiquitinated proteins is not due to an increase in de-
ubiquitination activity, we have also performed a de-ubiquitina-
tion assay and found that there are no significant changes in this
system with pregnancy and parturition (Fig. 8E).
Discussion
Characterization of cardiac physiological hypertrophy during
pregnancy [15] led us to speculate that the late pregnant heart is
‘‘a better functioning heart,’’ as contractile efficiency and capacity
is enhanced in response to increased force and stretch demand
[17]. Here we show for the first time that the activity of the total
26S ATP-dependent proteasome, polyubiquitinated protein levels
as well as the production of reactive oxygen species are reduced at
the end of pregnancy, all of which may support our previous
Figure 4. Transcript levels of proteasome 19S and 20S
subunits, as well as the regulatory subunit PA28a, are not
modified in late pregnancy. Relative transcript expression of the
cardiac proteasome measured by Real-Time qPCR in non pregnant (NP,
black bars), in late pregnancy (LP, white bars), 1 day post-partum (PP1,
grey bars) and 7 days post-partum (PP7, shaded bars) for RPN2 and
RPT4, which are subunits of 19 S (A–B), b2 and a7, which are subunits of
20 S (C–D) and the proteasome regulatory subunit PA28a (E). GAPDH
was used as the internal reference gene (data not shown). Values are
mean 6 SEM as normalized to NP (n = 3–5 per group).
doi:10.1371/journal.pone.0048601.g004
Figure 5. Protein levels of RPT4, RPN2, a7, PA28a and b5i are
unaffected by pregnancy. Immunoblotting of whole heart lysates
(100 mg) from non pregnant (NP, black bars), late pregnant (LP, white
bars), 1 day post-partum (PP1, grey bars) and 7 days post-partum (PP7,
shaded bars) with anti-RPN2 (A–B), -RPT4 (C–D), -a7 (E–F), -PA28a (G–H)
and -b5i (I–J) antibodies. In (I), the upper 30 kDa band is the b5i
containing the pro-peptide. The bar graphs represent the quantification
of fluorescent signal intensity normalized to Vinculin. For b5i both
bands were taken into consideration in the quantification of protein
levels. Vinculin was used as the loading control (n = 4 per group). Values
are mean 6 SEM in arbitrary units.
doi:10.1371/journal.pone.0048601.g005
Pregnancy and Cardiac Proteasome
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suggestion that a late pregnant heart is a better functioning heart.
We also found that the activity of the 26S ATP-dependent
proteasome was decreased in late pregnant hearts.
Proteasome Activity and Cardiac Hypertrophy
The heart is the only organ in the body that is constantly
bearing a heavy workload and a high metabolic rate. As such, it is
essential that cardiac cells maintain a very efficient and tightly
controlled system for removal of misfolded or damaged proteins
[18]. During cardiac hypertrophy, the increased protein synthesis
in cardiomyocytes could potentially result in an increase of
misfolded or aberrant proteins. An increase in 26S proteasomal
degradation could result in the clearance of these aberrantly folded
proteins. Alternatively, an increase in protein degradation by the
proteasome could lead to tissue atrophy. Although decreased
proteasome activities have been shown during the progression of
cardiac dysfunction [19], many studies report increased protea-
some activity in compensated heart hypertrophy induced by trans-
aortic constriction (TAC) both in mouse and canine models [20],
[21], while the proteasome inhibitor epoxomicin prevented the
development of pre-existing hypertrophy and the further reduction
in the ejection fraction [6], [19]. Both trypsin-like activity (b2) and
Figure 6. Increased nuclear labeling of core Subunits and RPT4 in late pregnancy was reversed one week postpartum. A.
Representative single confocal sections of cardiomyocytes dissociated from non pregnant (NP), late pregnant (LP), one day post-partum (PP1) and
seven days post-partum (PP7) are co-immunostained with anti-core (green) and -RPT4 (red) antibodies. The nuclear overlay of core and RPT4 are also
shown at higher resolution. These results are representative of the labeling pattern observed in myocytes from 3 different animals in each group. B.
Quantification of nuclear fluorescence labeling in the four groups mentioned above for core (green bars) and RPT4 (red bars) from at least 20–25 cells
per group (n = 3 mice/group). Only the nucleus in the confocal plane of focus was taken into account. **denotes p,0.001 vs. NP, #p,0.05 vs. LP and
‘p,0.05 vs. PP1.
doi:10.1371/journal.pone.0048601.g006
Pregnancy and Cardiac Proteasome
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chymotrypsin-like activities (b5) were significantly increased in the
subendocarium, which is subjected to the highest level of wall
stress in a canine model of left-ventricular hypertrophy [20], [21].
In fact, increased proteasome activity has been suggested to be
required for the development of compensated heart hypertrophy
[20], [21]. Although during pregnancy the heart also develops
compensated hypertrophy, the proteasome activity in this unique
model of hypertrophy is not increased. In fact, the activity of the
b1 and b2 subunits of the 26S proteasome is decreased in the LP
heart. The decrease in 26S proteasome activity was not reflected
by any changes in the inducible b5i subunit or in the PA28a
subunit of the 11S/PA28 regulator. In contrast, in isoproterenol-
induced cardiac hypertrophy, Drews et al. showed enhanced 26S
proteasome activities, with a concomitant significant decrease in
the caspase-like and trypsin-like 20S activities that may be due to a
switch in proteasome subpopulations, altered expression and
incorporation of the inducible b subunits [12].
Expression of Proteasome Subunits and Cardiac
Hypertrophy
Some controversy regarding the expression of proteasome
subunits at the mRNA and protein levels exists. Most reports show
an increase in 26S proteasome expression in different models of
cardiomyopathy and hypertrophy. Otsuka et al. report an increase
in 26S proteasome expression in patients suffering from dilated
cardiomyopathy, possibly due to a compensatory mechanism in
response to impaired proteasome activity [22]. Increased expres-
sion of the representative subunits of 19S (RPN2 and RPT11) and
20S (a6) have also been reported in the subendocarium of the
canine model of left ventricular hypertrophy [20]. However,
transcript levels of representative 20S subunits have been shown to
be decreased in failing hearts [19], suggesting possible post-
translational modifications. Here we did not observe any
significant differences in the transcript or protein levels of a7 (a
subunit of 20S), RPN2 and RPT4 (subunits of 19S) the regulatory
subunit PA28a and the inducible subunit b5i (protein levels only)
with pregnancy (Figs. 4, 5), further suggesting that pregnancy-
induced hypertrophy has a molecular signature unlike all other
models of hypertrophy that have previously been studied.
Pregnancy is Associated with Decreased Levels of
Ubiquitinated Proteins
Proteins that are targeted for degradation by the proteasome
must first initially be covalently tagged with ubiquitin molecules by
the E2–E3 ligase complex [9]. These ubiquitin molecules are then
recognized by the 19S regulatory particle of the 26S proteasome
complex in an ATP-dependent binding [23]. Therefore, protein
ubiquitination is one of the key mechanisms for targeting a peptide
to be degraded by the proteasome’s proteolytic pathway, and
ubiqutination levels are also important for the proteasome activity.
Here, we have found that pregnancy is associated with decreased
ubiquitinated protein levels (Fig. 8). Two independent methods
(Western Blot and ELISA) were utilized to show that the levels of
ubiquitination in the heart were decreased in late pregnancy
relative to non pregnant mice. However, unlike pregnancy,
immunocytochemical experiments previously revealed markedly
increased expression levels of ubiquitin in patients with decom-
pensated cardiomyopathy [22]. Increased ubiqutination levels
have also been reported in experimental models of pressure
overload-induced left ventricular hypertrophy in murine and
canine hearts [18], [19], [20]. Lower proteasome activity may
conserve energy as less ATP would be needed for protein
unfolding by the 19S complex and this may be beneficial to the
heart. Changes in protein ubiquitination can occur from changes
in proteasome activity, changes in de-ubiquitination activity or
changes in the ubiquitin-conjugating activity system (E1, E2 and
E3 enzymes). Lower proteasome activities are unlikely to cause
lower polyubiquitination levels since the proteasome readily
degrades polyubiquitinated proteins. Investigation of the de-
ubiquitination activity showed that the total de-ubiquitination
activity was not significantly affected by pregnancy. These results
suggest that the ubiquitin-conjugating activity system may be
lowered by pregnancy. It is possible that the proteasome has
potentially less substrates (less polyubiquitinated proteins) to
degrade post-translational modifications (which are known to
affect the activity of the proteasome [13], [14]), which may be
responsible for the reduced activity of the proteasome since the
proteasomal gene and protein expression seems to be unchanged.
Reactive Oxygen Species Production and the 26S
Proteasome
The proteasomal system has previously been shown to be the
major proteolytic system involved in the removal of oxidized
proteins, with the 26S proteasome being the most sensitive to
oxidative stress [16]. Although the 26S proteasome generally
functions as part of the ubiquitin-proteasome pathway, it also has
Figure 7. Superoxide production is decreased with pregnancy
and remains low seven days after parturition. A. Representative
dihydroethidium (DHE) staining of transverse heart sections in non
pregnant (NP), late pregnant (LP), 1 day post-partum (PP1) and 7 days
post-partum (PP7). Red staining indicates the presence of reactive
oxygen species (ROS). B. Quantification of the DHE staining for
detection of ROS in non pregnant (NP, black bar), late pregnant (LP,
white bar), 1 day post-partum (PP1, grey bar) and 7 days post-partum
(PP7, shaded bar). Values are mean 6 SEM as normalized to NP (n = 3
per group), and **denotes p,0.001 vs. NP, #p,0.05 vs. LP and ‘p,0.05
vs. PP1.
doi:10.1371/journal.pone.0048601.g007
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the capacity to degrade certain unfolded or damaged proteins,
including ‘‘aged’’, denatured proteins, or proteins that have been
oxidatively damaged, without initial ubiquitin tagging [13], [24].
We observed that the reactive oxygen species (ROS) generated in
pregnancy is decreased and remains low one week after delivery
(Fig. 6). ROS has been previously shown to increase the ubiquitin-
conjugating activity and expression of genes for E3 enzymes
(MuRF1 and MaFbx) in skeletal muscle myotubes [25]. Lower
levels of ROS may account for the decreased polyubiquitination
levels in the LP hearts.
Hormones and Proteasome Activity
It is also possible that estrogen may affect the proteasome, as
interferon-induced oxidative stress has been shown to be
associated with decreased proteasome amount and increased
polyubiquitination [26]. Hormones, either directly or via the
control of the metabolic status, can affect the ubiquitin-mediated
control of protein degradation, as glucocorticoids have previously
been shown to cause catabolic protein breakdown [27]. In skeletal
muscle, degradation of cell proteins is of major physiological
importance, and the size of a muscle cell is tightly regulated by the
overall rate of proteolysis, a process precisely regulated by
hormones and cytokines [28]. Lastly, Genistein, a soy isoflavone
with affinity for the estrogen receptor beta, has been shown to
inhibit 20S proteasome activity in human prostate cancer cells
[29]. The level of estrogen drastically increases at the end of
pregnancy, but it is not clear whether estrogen treatment could
regulate proteasome activity in the heart. Here we report for the
first time that estrogen did not have any effect on the three
proteolytic activities of the murine cardiac 26S proteasome. Thus,
the changes in proteasome activity occurring in pregnancy cannot
be attributed to the surge of estrogen.
Taken together, our results suggest that the ubiquitination,
proteasome proteolytic pathway and the production of reactive
oxygen species are affected by pregnancy. Late pregnancy is
associated with a decrease in the polyubiquitination levels, which
could be explained at least in part by reduced ROS production.
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Figure 8. Pregnancy is associated with decreased polyubiquitinated protein levels, but not de-ubiqutination levels. A. Representative
Western Blot of polyubiquitinated proteins (using the FK2 antibody) in whole heart lysates (100 mg) from non pregnant (NP), late pregnant (LP), 1 day
post-partum (PP1) and 7 days post-partum (PP7). B. PonceauS was used as the loading control (n = 4 per group). C. Quantification of the
polyubiquitinated proteins by Western Blot in non-pregnant (NP, black bar), late pregnant (LP, white bar), 1 day post-partum (PP1, grey bar) and 7
days post-partum (PP7, shaded bar). D. Polyubiquitination levels in NP, LP, PP1 and PP7 as determined by ELISA (using the FK1 antibody). E. De-
ubiquitination activity levels in NP, LP, PP1 and PP7. Values are mean 6 SEM and are normalized to NP, n = 4 per group and * denotes p,0.05 vs. NP.
doi:10.1371/journal.pone.0048601.g008
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